News & Event

October 2022

Presenting at the ACADEMY 2022 SAN DIEGO

October 2022

October 2022 RevitalVision at EPOS 2022 Munich

September 2022

Israel: A beacon of light helping with sight

This special feature article in GeekTime profiles innovative optics treatments and technologies from leading start-ups.

September 2022

RevitalVision will present at ESCRS2022

We will be presenting at the 40th annual congress of The European Society for Cataract and Refractive Surgery (ESCRS) in Milan, Italy, from 16-19 September 2022.

March 2022

New randomized controlled trial on RevitalVision

Effects of Perceptual Learning on Deprivation Amblyopia in Children with Limbal Dermoid: A Randomized Controlled Trial.

The study compared 2 groups of children with amblyopia after corneal transplant : One group received standard patching therapy and the second group received patching + RevitalVision.

The group that underwent RevitalVision therapy experienced statistically significant improvement in vision.

March 2022

RevitalVision at HIMSS 22

This year, the Israel Export Institute together with the Foreign Trade Administration – Ministry of Economy & Industry will present 18Israeli Digital Health companies. And we are proud to be amongst these innovative companies

March 2022

RevitalVision will present at the AAPOS 2022 – Arizona

2022 Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS), on March 23-27, 2022.

November 2021

RevitalVision on The Ophthalmologist

Yair Yahav, CEO and founder of RevitalVision, was interviewed in The Ophthalmologist about how we improve vision in adult amblyopia and other eye diseases and vision impairments

12-15 November 2021

AAO annual meeting

Come meet our experts at the AAO annual meeting, taking place in New Orleans this November

3-6 November 2021

American Academy of Optometry Annual Meeting

We’re excited to be one of the exhibitors at the American Academy of Optometry Annual Meeting – which will be taking place in Boston

Visit us in the exhibit hall at booth #843

July 2021

RevitalVision received reimbursement code in the USA

RevitalVision is a standalone therapeutic vision training software, the only FDA-approved product for market, and clinically proven to improve vision in adult amblyopia (age 9-plus), received a unique Current Procedural Terminology (CPT) reimbursement code from the American Medical Association (AMA).

14/08/2020

RevitalVision recieves R&D grant from the Israeli Innovation Authority

01/08/2020

WSPOS – World Wide Webinar on Amblyopia – Sponsored by REVITALVISION

2020

A New Adult Amblyopia study presented at AIOS 2020 (All India Ophthalmology Society)

meeting 2020 confirming again the efficacy of RevitalVision in improving vision in adult amblyopia

7 October

REVITALVISION will participate at the upcoming AAOPT (AMERICAN ACADEMY of OOPTOMETRY)

Meeting in Nashville, TN, USA 7-10 October

21-24 April 2021

REVITALVISION will participate at the upcoming 41st ESA (EUROPEAN STRABISMOLOGICAL ASSOCIATION)

Meeting in PARIS 21th /24th April 2021

2020

Tel Aviv Medical Center is recruiting Age related Macular Degeneration patients for a REVITALVISION clinical study

A Proof-of-Concept, Prospective, Open label, Randomized Clinical Study Evaluating RevitalVision® Therapy for Improving Best Corrected Visual Acuity (BCVA) and Contrast Sensitivity Function (CSF) in Patients Suffering from stabler Age related Macular Degeneration (AMD)